“They have produced a vaccine, but we doubt if COVID-19 exists”: correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria

References

• Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60. doi:10.23750/abm.v91i1.9397.
   PubMedGoogle Scholar
• World Health Organization (WHO). [accessed 2021 May 25]. https://covid19.who.int .
   Google Scholar
• Johns Hopkins University. [accessed 2021 May 25]. https://coronavirus.jhu.edu .
   Google Scholar
• Nigeria Centre for Disease Control (NCDC). [accessed 2021 May 25]. https://covid19.ncdc.gov.ng .
   Google Scholar
• Lurie N, Sharfstein JM, Goodman JL. The development of COVID-19 vaccines: safeguards needed. JAMA. 2020;324(5):439–40. doi:10.1001/jama.2020.12461.
   PubMed Web of Science ®Google Scholar
• Nachega JB, Sam-Agudu NA, Masekela R, van der Zalm MM, Nsanzimana S, Condo J, Ntoumi F, Rabie H, Kruger M, Wiysonge CS, et al. Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Glob Health. 2021;9(6):e746–8. doi:10.1016/S2214-109X(21)00097-8.
   PubMed Web of Science ®Google Scholar
• Editorial. Vaccine hesitancy: a generation at risk. Lancet Child Adolesc Health. 2019;3(5):281. doi:10.1016/S2352-4642(19)30092-6.
   PubMedGoogle Scholar
• Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Global Health. 2020;5:e004206. doi:10.1136/bmjgh-2020-004206.
   PubMed Web of Science ®Google Scholar
• Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–93. doi:10.1080/21645515.2020.1780846.
   PubMed Web of Science ®Google Scholar
• Randolph HE, Barreiro LB. Herd Immunity: understanding COVID-19. Immunity. 2020;52(5):737–41. doi:10.1016/j.immuni.2020.04.012.
   PubMed Web of Science ®Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160. doi:10.3390/vaccines9020160.
   PubMed Web of Science ®Google Scholar
• Samarasekera U. Feelings towards COVID-19 vaccination in Africa. Lancet. 2021;21:324. doi:10.1016/S1473-3099(21)00082-7.
   Web of Science ®Google Scholar
• Tobin EA, Okonofua M, Azeke A, Ajekweneh V, Akpede G. Willingness to accept a covid-19 vaccine in Nigeria: a population-based cross-sectional study. Cent Afr J Public Health. 2021;7(2):53–60. doi:10.11648/j.cajph.20210702.12.
   Google Scholar
• Adebisi YA, Alaran AJ, Bolarinwa OA, Akande-Sholabi W, Lucero-Prisno III DE. When it is available, will we take it? Social media users’ perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afr Med J. 2021;38(230). doi:10.11604/pamj.2021.38.230.27325.
   PubMedGoogle Scholar
• Ilesanmi O, Afolabi A, Uchendu O. The prospective COVID-19 vaccine: willingness to pay and perception of community members in Ibadan, Nigeria. PeerJ. 2021;9:e11153. doi:10.7717/peerj.11153.
   PubMed Web of Science ®Google Scholar
• Eniade OD, Olarinmoye A, Otovwe A, Akintunde FE, Okedare OO, Aniyeloye AO. Willingness to accept COVID-19 vaccine and its determinants among Nigeria citizens: a web-based cross-sectional study. J Adv Med Med Res. 2021;33(8):13–22. doi:10.9734/jammr/2021/v33i830881.
   Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
   PubMed Web of Science ®Google Scholar
• Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–77. doi:10.1007/s10900-020-00958-x.
   PubMed Web of Science ®Google Scholar
• Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):1–15. doi:10.1038/s41467-020-20226-9.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):29. doi:10.1038/s41467-020-20226-9.
   PubMed Web of Science ®Google Scholar
• Tobin EA, Okonofua M, Azeke A, Ajekweneh V, Akpede G. Willingness to accept a COVID-19 vaccine in Nigeria: a population-based cross-sectional study. J Med Res. 2021;5:1–15.
   Google Scholar
• Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594.
   PubMed Web of Science ®Google Scholar
• Germani F, Biller-Andorno N. The anti-vaccination infodemic on social media: a behavioral analysis. PLoS ONE. 2021;16(3):e0247642. doi:10.1371/journal.pone.0247642.
   PubMed Web of Science ®Google Scholar
• Daly M, Jones A, Robinson E. Public trust and willingness to vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021. JAMA. 2021 May 24;325(23):2397. doi:10.1001/jama.2021.8246.
   PubMed Web of Science ®Google Scholar
• Kapp C. Nigerian states again boycott polio-vaccination drive. Muslim officials have rejected assurances that the polio vaccine is safe–leaving Africa on the brink of reinfection. Lancet. 2004;363(9410):709. doi:10.1016/s0140-6736(04)15665-1.
   PubMedGoogle Scholar
• Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med. 2007;4(3):e73. doi:10.1371/journal.pmed.0040073.
   PubMed Web of Science ®Google Scholar
• Clements CJ, Greenough P, Shull D. How vaccine safety can become political–the example of polio in Nigeria. Curr Drug Saf. 2006;1(1):117–19. doi:10.2174/157488606775252575.
   PubMedGoogle Scholar
• Ghinai I, Willott C, Dadari I, Larson HJ. Listening to the rumours: what the northern Nigeria polio vaccine boycott can tell us ten years on. Glob Public Health. 2013;8(10):1138–50. doi:10.1080/17441692.2013.859720.
   PubMed Web of Science ®Google Scholar
• Wise J. Pfizer accused of testing new drug without ethical approval. BMJ. 2001;322(7280):194. doi:10.1136/bmj.322.7280.194.
   PubMedGoogle Scholar
• National Bureau of Statistics. Demographic statistics bulletin 2017. 2018 May [accessed 2021 Aug 2]:7–8. https://nigerianstat.gov.ng.
   Google Scholar
• Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva, Switzerland: World Health Organization; 1991. 29–32.
   Google Scholar
• Olomofe CO, Soyemi VK, Udomah BF, Owolabi AO, Ajumuka EE, Igbokwe CM, Ashaolu UO, Adeyemi AO, Aremu-Kasumu YB, Dada OF, et al. Predictors of uptake of a potential Covid-19 vaccine among Nigerian adults. J Vaccines Vaccin. 2021;12:442.
   Google Scholar
• Freeman D, Loe BS, Chadwick A. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2021:1–15. doi:10.1017/S0033291720005188.
   Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221. doi:10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Kim H. Statistical notes for clinical researchers: chi-squared test and Fisher’s exact test. Resor Dent Endod. 2017;42(2):152–55. doi:10.5395/rde.2017.42.2.152.
   PubMedGoogle Scholar
• Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: logistic regression. Perspect Clin Res. 2017 Jul-Sep;8(3):148–51. doi:10.4103/picr.PICR_87_17.
   PubMedGoogle Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): Wiley; 2013.
   Google Scholar
• Pope C, Ziebland S, Mays N. Qualitative research in health care. Analyzing qualitative data. BMJ. 2000;320(7227):114–16. doi:10.1136/bmj.320.7227.114.
   PubMed Web of Science ®Google Scholar
• Farmer T, Robinson K, Elliott SJ, John ED. Developing and implementing a triangulation protocol for qualitative health research. Qual Health Res. 2006;16:377. doi:10.1177/1049732305285708.
   PubMed Web of Science ®Google Scholar
• Akinyemi PA, Fajobi O, Owoade IA, Elugbaju OT, Wuraola FO. Community perception and determinants of willingness to uptake COVID-19 vaccines among residents of Osun State, South-West Nigeria. Int J Community Med Public Health. 2021;8(4):1551–57. doi:10.18203/2394-6040.ijcmph20211202.
   Google Scholar
• Habib MA, Dayyab FM, Iliyasu G, Habib AG. Knowledge, attitude and practice survey of COVID-19 pandemic in Northern Nigeria. PLoS One. 2021;16(1):e0245176. doi:10.1371/journal.pone.0245176.
   PubMed Web of Science ®Google Scholar
• Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
   PubMedGoogle Scholar
• Rice BL, Annapragada A, Baker RE, Bruijning M, Dotse-Gborgbortsi W, Mensah K, Miller IF, Motaze NV, Raherinandrasana A, Rajeev M, et al. Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa. Nat Med. 2021;27:447–53. doi:10.1038/s41591-021-01234-8.
   PubMed Web of Science ®Google Scholar
• Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, Sanderson C, McKee M, Troeger C, Ong KL, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020 Aug8;8:e1003–e1017. doi:10.1016/S2214-109X(20)30264-3.
   PubMed Web of Science ®Google Scholar
• Al-Qerem WA, Jarab AS. COVID-19 vaccination acceptance and its associated factors among a middle eastern population. Front Public Health. 2021;9:632914. doi:10.3389/fpubh.2021.632914.
   PubMed Web of Science ®Google Scholar
• Enitan SS, Oyekale AO , Akele RY , Olawuyi KA, Olabisi EO, Nwankiti AJ, Adejumo EN , Enitan CB. Assessment of knowledge, perception and readiness of Nigerians to participate in the COVID-19 vaccine trial. Int J Vaccine Immunizat. 2020;4(1). doi:10.16966/2470-9948.123.
   Google Scholar
• Alobaidi S. Predictors of intent to receive the COVID-19 vaccination among the population in the Kingdom of Saudi Arabia: a survey study. J Multidiscip Healthc. 2021;14:1119–28. doi:10.2147/JMDH.S306654.
   PubMed Web of Science ®Google Scholar
• Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health. 2021;21:818. doi:10.1186/s12889-021-10862-1.
   PubMed Web of Science ®Google Scholar
• Choi WS, Cheong HJ. COVID-19 vaccination for people with comorbidities. Infect Chemother. 2021;53(1):155–58. doi:10.3947/ic.2021.0302.
   PubMed Web of Science ®Google Scholar
• Wiedemann PM, Schütz H. The precautionary principle and risk perception: experimental studies in the EMF area. Env Health Perspect. 2005;113:402–05. doi:10.1289/ehp.7538.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N Engl J Med. 2021;384(20):1885–98. doi:10.1056/NEJMoa2102214.
   PubMed Web of Science ®Google Scholar
• Irfan N, Chagla Z. In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant). Ann Intern Med. 2021;174(5):JC50. doi:10.7326/ACPJ202105180-050.
   PubMed Web of Science ®Google Scholar